Drugs / EAPA115
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04231136 Comparator | Jan → Jul 2020 | — | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EAPA115 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04231136 ↗ |
| Route | Oral | “Oral administration of EAPA115 once a day” NCT04231136 ↗ |